This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Perrault, A. Articles by Wolfson, C. Search for Related Content PubMed PubMed Citation Articles by Perrault, A. Articles by Wolfson, C. Pubmed/NCBI databases Medline Plus Health Information Alzheimer's Disease Mental Health Genetics Home Reference Social Bookmarking                   What's this?

Review of Outcome Measurement Instruments in Alzheimer's Disease Drug Trials: Psychometric Properties of Behavior and Mood Scales

Mark Oremus, MSc

Louise Demers, PhD

Stephen Vida, MD

Christina Wolfson, PhD

This article reviews the reliability and validity of eight scales for behavior and mood problems that were identified in a comparative analysis ofAlzheimer's disease (AD) drug trials. The scales are the Brief Psychiatric Rating Scale, the Alzheimer's Disease Assessment Scale-noncognitive, the Relative's Assessment of Global Symptomatology, the Consortium to Establish a Registry for Alzheimer's Disease-Behavior Rating Scale for Dementia, the Dementia Behavior Disturbance scale, the Neuropsychiatric Inventory, and two scales for depressive symptoms, the Cornell Scale for Depression in Dementia and the Dementia Mood Assessment Scale. This article also examines methodological limitations in the way the published literature has assessed the psychometric properties of these scales. The aim is to help clinicians and potential trial investigators select appropriate measurement instruments with which to assess behavior and mood problems in AD and to assist AD researchers in the evaluation of the psychometric properties of such scales. (J Geriatr Psychiatry Neurol 2000; 13:181-196).

Journal of Geriatric Psychiatry and Neurology, Vol. 13, No. 4, 181-196 (2000)
DOI: 10.1177/089198870001300403


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. Ramirez-Montealegre and D. A. Pearce Imaging of late infantile neuronal ceroid lipofuscinosis: A clinical rating scale Neurology, August 7, 2007; 69(6): 503 - 504. [Full Text] [PDF]

				F. Ortiz, L. J. Fitten, J. L. Cummings, S. Hwang, and M. Fonseca Neuropsychiatric and behavioral symptoms in a community sample of Hispanics with Alzheimer's disease. American Journal of Alzheimer's Disease and Other Dementias, August 1, 2006; 21(4): 263 - 273. [Abstract] [PDF]

				N.-H. Trinh, J. Hoblyn, S. Mohanty, and K. Yaffe Efficacy of Cholinesterase Inhibitors in the Treatment of Neuropsychiatric Symptoms and Functional Impairment in Alzheimer Disease: A Meta-analysis JAMA, January 8, 2003; 289(2): 210 - 216. [Abstract] [Full Text] [PDF]